Pediatric venous thromboembolism (VTE) is associated with increased costs, morbidity, and mortality; however, its prevalence at Advocate Children’s Hospital (ACH) was unknown prior to joining the Solutions for Patient Safety (SPS). SPS is a national network aiming at reducing harm in pediatrics. In 2015, ACH had 18 hospital VTEs in patients aged 6 months through 17 years, the second most common hospital-acquired condition for the hospital and the network.
- Nursing Management for the Successful Application of the Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy (212)
- Beyond Pain Crises: Acute Complications of Sickle Cell Disease (202)
- Central Line-Associated Bloodstream Infections in Pediatric Hem/Onc/BMT Patients: An Update and Appraisal of the Evidence (203)
- Paper Presentations: Hospital-Acquired Conditions and Challenges — Avoiding the Bite: Implementation of the St. Jude Advanced Warning Score (sJAWS) System (204-2)
- Paper Presentations: Hospital-Acquired Conditions and Challenges — Applying Evidence Based Pressure Ulcer Prevention to Pediatric Hematology/Oncology Patients: A Pilot (204-3)